Strategic Financial Concepts’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,503	Closed	-$9.47K	–	235
2023 Q3	$9.47K	Hold	1,503	–	–	﹤0.01%	267
2023 Q2	$12.5K	Hold	1,503	–	–	﹤0.01%	254
2023 Q1	$6.61K	Buy	+1,503	New	+$6.61K	﹤0.01%	241